BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 15211591)

  • 1. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T; Perez-Polo JR; Schliebs R
    J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease-relevant genes and proteins.
    Zuchner T; Schliebs R; Perez-Polo JR
    J Neurochem; 2005 Oct; 95(1):20-32. PubMed ID: 16181410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
    Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y
    Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
    Rossner S; Sastre M; Bourne K; Lichtenthaler SF
    Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M1 muscarinic acetylcholine receptor interacts with BACE1 and regulates its proteosomal degradation.
    Jiang S; Wang Y; Ma Q; Zhou A; Zhang X; Zhang YW
    Neurosci Lett; 2012 May; 515(2):125-30. PubMed ID: 22450048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells.
    Li Q; Wu D; Zhang L; Zhang Y
    Exp Gerontol; 2010 Nov; 45(11):842-7. PubMed ID: 20600777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
    Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
    Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.
    Rossner S; Lange-Dohna C; Zeitschel U; Perez-Polo JR
    J Neurochem; 2005 Jan; 92(2):226-34. PubMed ID: 15663471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
    Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
    J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells.
    Schliebs R; Heidel K; Apelt J; Gniezdzinska M; Kirazov L; Szutowicz A
    Brain Res; 2006 Nov; 1122(1):78-85. PubMed ID: 17026971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of g protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscarinic acetylcholine receptor signaling.
    Willets JM; Mistry R; Nahorski SR; Challiss RA
    Mol Pharmacol; 2003 Nov; 64(5):1059-68. PubMed ID: 14573754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains.
    Harada H; Tamaoka A; Ishii K; Shoji S; Kametaka S; Kametani F; Saito Y; Murayama S
    Neurosci Res; 2006 Jan; 54(1):24-9. PubMed ID: 16290302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
    Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presenilin 1 is involved in the maturation of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).
    Kuzuya A; Uemura K; Kitagawa N; Aoyagi N; Kihara T; Ninomiya H; Ishiura S; Takahashi R; Shimohama S
    J Neurosci Res; 2007 Jan; 85(1):153-65. PubMed ID: 17075903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
    Onyango IG; Tuttle JB; Bennett JP
    Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APP processing is regulated by cytoplasmic phosphorylation.
    Lee MS; Kao SC; Lemere CA; Xia W; Tseng HC; Zhou Y; Neve R; Ahlijanian MK; Tsai LH
    J Cell Biol; 2003 Oct; 163(1):83-95. PubMed ID: 14557249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.